These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 15535299

  • 1. [Therapy for ovarian cancer--general review].
    Ochiai K.
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():517-21. PubMed ID: 15535299
    [No Abstract] [Full Text] [Related]

  • 2. [Chemotherapy for ovarian cancer--introduction].
    Yamada H, Sugiyama T.
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():540-5. PubMed ID: 15535304
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical characteristics and therapeutic variations in elderly patients with ovarian cancer].
    Kihana T.
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():632-5. PubMed ID: 15535322
    [No Abstract] [Full Text] [Related]

  • 4. [Prognostic factors of ovarian cancer].
    Ochiai K.
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2014-9. PubMed ID: 17197745
    [Abstract] [Full Text] [Related]

  • 5. Comparison of combination therapy with paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with suboptimal stage III and stage IV ovarian cancer: a Gynecologic Oncology Group study.
    McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M.
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-13-S2-16. PubMed ID: 9045329
    [Abstract] [Full Text] [Related]

  • 6. Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group).
    McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M.
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):40-7. PubMed ID: 8941409
    [Abstract] [Full Text] [Related]

  • 7. Carcinoma erysipeloides from ovarian clear-cell carcinoma.
    Lee HC, Chu CY, Hsiao CH.
    J Clin Oncol; 2007 Dec 20; 25(36):5828-30. PubMed ID: 18089882
    [No Abstract] [Full Text] [Related]

  • 8. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.
    McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M.
    N Engl J Med; 1996 Jan 04; 334(1):1-6. PubMed ID: 7494563
    [Abstract] [Full Text] [Related]

  • 9. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
    Wu LY, Zhang R, Huang MN, Li N, Wang GX, Liu LY.
    Ai Zheng; 2003 Apr 04; 22(4):424-7. PubMed ID: 12704005
    [Abstract] [Full Text] [Related]

  • 10. [Ovarian cancer treatment from the standpoint of the gynecologic oncologist].
    Sugiyama T, Yoshizaki A, Hatayama S.
    Gan To Kagaku Ryoho; 2007 Jul 04; 34(7):1011-6. PubMed ID: 17637537
    [Abstract] [Full Text] [Related]

  • 11. [A case of ovarian cancer stage IV and advanced rectal cancer responding to paclitaxel/carboplatin].
    Kawaguchi R, Furukawa N, Morimoto Y, Ohi M, Osawa T, Koike H, Miyake T.
    Gan To Kagaku Ryoho; 2004 Apr 04; 31(4):619-22. PubMed ID: 15114712
    [Abstract] [Full Text] [Related]

  • 12. [Update of ovarian carcinoma].
    Shimizu Y.
    Gan To Kagaku Ryoho; 1998 Sep 04; 25(11):1680-8. PubMed ID: 9757192
    [Abstract] [Full Text] [Related]

  • 13. [Combined organ resection in cytoreductive surgery for ovarian cancer].
    Goto T, Takeda S.
    Nihon Rinsho; 2004 Oct 04; 62 Suppl 10():531-4. PubMed ID: 15535302
    [No Abstract] [Full Text] [Related]

  • 14. [Radical surgery for ovarian cancer].
    Ochiai K, Takakura S, Kawashima M.
    Gan To Kagaku Ryoho; 1992 Oct 04; 19(12):1977-81. PubMed ID: 1417006
    [Abstract] [Full Text] [Related]

  • 15. Recent advances in the management of women with ovarian cancer.
    Eltabbakh GH.
    Minerva Ginecol; 2004 Feb 04; 56(1):81-9. PubMed ID: 14973412
    [Abstract] [Full Text] [Related]

  • 16. [Developments in the therapy of advanced FIGO III ovarian cancer].
    Kuhn W, Jänicke F, Pache L, Hölscher M, Schattenmann G, Schmalfeldt B, Anderl H, Schüle G, Dettmar P, Siewert JR.
    Geburtshilfe Frauenheilkd; 1993 May 04; 53(5):293-302. PubMed ID: 8514099
    [Abstract] [Full Text] [Related]

  • 17. Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival?
    Eisenkop SM, Spirtos NM.
    Gynecol Oncol; 2001 Sep 04; 82(3):435-41. PubMed ID: 11520137
    [Abstract] [Full Text] [Related]

  • 18. A phase I/II study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy of poor-prognosis advanced-stage epithelial ovarian cancer.
    Kohn EC, Sarosy GA, Davis P, Christian M, Link CE, Ognibene FP, Sindelar WF, Jacob J, Steinberg SM, Premkumar A, Reed E.
    Gynecol Oncol; 1996 Aug 04; 62(2):181-91. PubMed ID: 8751547
    [Abstract] [Full Text] [Related]

  • 19. Observations on the interpretation of clinical trials in early ovarian cancer.
    Swart AM, Parmar MK.
    J Clin Oncol; 2005 Feb 01; 23(4):927; author reply 937-8. PubMed ID: 15681549
    [No Abstract] [Full Text] [Related]

  • 20. Medical treatment of epithelial ovarian cancer.
    González-Martín AJ.
    Expert Rev Anticancer Ther; 2004 Dec 01; 4(6):1125-43. PubMed ID: 15606338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.